A detailed history of Goldman Sachs Group Inc transactions in Globus Medical Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 723,467 shares of GMED stock, worth $58.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
723,467
Previous 425,286 70.11%
Holding current value
$58.1 Million
Previous $30.4 Million 96.68%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$69.79 - $85.61 $20.8 Million - $25.5 Million
298,181 Added 70.11%
723,467 $59.8 Million
Q3 2024

Nov 14, 2024

BUY
$67.08 - $73.92 $319,233 - $351,785
4,759 Added 1.13%
425,286 $30.4 Million
Q2 2024

Aug 13, 2024

BUY
$49.79 - $68.85 $12.6 Million - $17.5 Million
253,706 Added 152.08%
420,527 $28.8 Million
Q1 2024

May 15, 2024

SELL
$51.15 - $56.52 $3.89 Million - $4.3 Million
-76,079 Reduced 31.32%
166,821 $8.95 Million
Q4 2023

Feb 13, 2024

BUY
$43.79 - $55.14 $3.37 Million - $4.25 Million
77,070 Added 46.48%
242,900 $12.9 Million
Q3 2023

May 14, 2024

SELL
$49.1 - $62.37 $3.78 Million - $4.81 Million
-77,070 Reduced 31.73%
165,830 $8.23 Million
Q3 2023

Nov 14, 2023

BUY
$49.1 - $62.37 $1.83 Million - $2.32 Million
37,275 Added 29.0%
165,830 $8.23 Million
Q2 2023

May 14, 2024

SELL
$52.61 - $59.54 $15.6 Million - $17.7 Million
-297,023 Reduced 69.79%
128,555 $7.65 Million
Q2 2023

Aug 14, 2023

SELL
$52.61 - $59.54 $15.6 Million - $17.7 Million
-297,023 Reduced 69.79%
128,555 $7.65 Million
Q1 2023

May 14, 2024

BUY
$51.83 - $79.63 $13.1 Million - $20.2 Million
253,650 Added 147.53%
425,578 $24.1 Million
Q1 2023

May 11, 2023

BUY
$51.83 - $79.63 $13.1 Million - $20.2 Million
253,650 Added 147.53%
425,578 $24.1 Million
Q4 2022

May 14, 2024

SELL
$58.4 - $75.53 $965,644 - $1.25 Million
-16,535 Reduced 8.77%
171,928 $12.8 Million
Q4 2022

Feb 13, 2023

SELL
$58.4 - $75.53 $965,644 - $1.25 Million
-16,535 Reduced 8.77%
171,928 $12.8 Million
Q3 2022

May 14, 2024

SELL
$55.32 - $67.54 $816,191 - $996,485
-14,754 Reduced 7.26%
188,463 $11.2 Million
Q3 2022

Nov 10, 2022

SELL
$55.32 - $67.54 $816,191 - $996,485
-14,754 Reduced 7.26%
188,463 $11.2 Million
Q2 2022

May 14, 2024

SELL
$53.08 - $81.37 $2.11 Million - $3.23 Million
-39,683 Reduced 16.34%
203,217 $11.4 Million
Q2 2022

Aug 15, 2022

BUY
$53.08 - $81.37 $264,285 - $405,141
4,979 Added 2.51%
203,217 $11.4 Million
Q1 2022

May 16, 2022

BUY
$63.68 - $75.54 $2.85 Million - $3.38 Million
44,779 Added 29.18%
198,238 $14.6 Million
Q4 2021

Feb 14, 2022

SELL
$62.62 - $79.92 $6.51 Million - $8.31 Million
-103,942 Reduced 40.38%
153,459 $11.1 Million
Q3 2021

Nov 10, 2021

BUY
$76.41 - $84.06 $19.7 Million - $21.6 Million
257,401 New
257,401 $19.7 Million

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.19B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.